Enhancing Pharmaceutical Research and Development through Artificial Intelligence and Machine Learning: A Paradigm Shift in Computational Drug Design and Clinical Excellence
Journal of Artificial Intelligence and Digital Health · 24.06.2026 · 1 (1) · 63
DOI: 10.67238/jaid.2026.v1.09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Artificial Intelligence and Digital Health, online erschienen am 24.06.2026. Verfasst von Raveendra Ramachandra.
Abstract (Originalsprache)
The pharmaceutical landscape is undergoing a paradigm shift driven by Artificial Intelligence (AI) and Machine Learning (ML). This paper explores the transition from traditional empirical methods to data-driven discovery, focusing on drug design, clinical trials, and patient-centric healthcare delivery. By integrating predictive modeling and advanced computational architectures, the pharmaceutical industry is transitioning from serendipity-driven discovery to targeted, high-throughput precision medicine [1].
Zitieren
APA
Ramachandra, R. (2026). Enhancing Pharmaceutical Research and Development through Artificial Intelligence and Machine Learning: A Paradigm Shift in Computational Drug Design and Clinical Excellence. Journal of Artificial Intelligence and Digital Health, 1(1), 63. https://doi.org/10.67238/jaid.2026.v1.09
Vancouver
Ramachandra R. Enhancing Pharmaceutical Research and Development through Artificial Intelligence and Machine Learning: A Paradigm Shift in Computational Drug Design and Clinical Excellence. Journal of Artificial Intelligence and Digital Health. 2026;1(1):63. doi:10.67238/jaid.2026.v1.09
BibTeX
@article{Ramachandra2026,
author = {Ramachandra, Raveendra},
title = {Enhancing Pharmaceutical Research and Development through Artificial Intelligence and Machine Learning: A Paradigm Shift in Computational Drug Design and Clinical Excellence},
journal = {Journal of Artificial Intelligence and Digital Health},
year = {2026},
volume = {1},
number = {1},
pages = {63},
doi = {10.67238/jaid.2026.v1.09}
}
EUVIMED